استرازينيكا تطعيم. كوفاكس: مصر تتلقى أكثر من 850 ألف جرعة من لقاح أسترازينيكا

There were not enough results in older participants over 55 years old to provide a figure for how well the vaccine will work in this group	A summary of the RMP is available
The decision on whether to use the vaccine in pregnant women should be made in close consultation with a healthcare professional after considering the benefits and risks	Detailed information about this vaccine is available in the , which includes the

لقاح أكسفورد

Mallapaty, Smriti; Callaway, Ewen 2021-03-24.

كوفاكس: مصر تتلقى أكثر من 850 ألف جرعة من لقاح أسترازينيكا: The adenovirus in the vaccine cannot reproduce and does not cause disease
كوفاكس: مصر تتلقى أكثر من 850 ألف جرعة من لقاح أسترازينيكا: If, later on, the person comes into contact with SARS-CoV-2 virus, their immune system will recognise it and be ready to defend the body against it
كوفاكس: مصر تتلقى أكثر من 850 ألف جرعة من لقاح أسترازينيكا: Vaxzevria offers a good level of protection against COVID-19 which is a critical need in the current pandemic

These trials and additional studies will provide information on how long protection lasts, including against new variants of the virus, how well the vaccine prevents severe COVID-19, how well it protects older people, immunocompromised people, children and pregnant women, and whether it prevents asymptomatic cases	Walsh, Nick; Shelley, Jo; Duwe, Eduardo; Bonnett, William 27 July 2020
As for all medicines, data on the use of Vaxzevria are continuously monitored	Most side effects are mild to moderate in severity and are gone within a few days

There were no additional side effects in the 345 people who received Vaxzevria in the trial and had previously had COVID-19.

كوفاكس: مصر تتلقى أكثر من 850 ألف جرعة من لقاح أسترازينيكا: The cells will use the gene to produce the spike protein
كوفاكس: مصر تتلقى أكثر من 850 ألف جرعة من لقاح أسترازينيكا: The other two studies had fewer than 6 COVID-19 cases occurring in each, which was not enough to measure the preventive effect of the vaccine
لقاح أكسفورد: Preliminary animal studies do not show any harmful effects in pregnancy, however data on the use of Vaxzevria during pregnancy are very limited

In addition, as the vaccine is to be given as two standard doses, and the second dose should be given between 4 and 12 weeks after the first, the Agency concentrated on results involving people who received this standard regimen	Woo, Jenny Strasburg and Stu October 21, 2020
Woo, Jenny Strasburg and Stu October 21, 2020	Annex IIIB - Please note that the size of the above document can exceed 50 pages

"Covid-19: The E484K mutation and the risks it poses".

كوفاكس: مصر تتلقى أكثر من 850 ألف جرعة من لقاح أسترازينيكا: Can people with allergies be vaccinated with Vaxzevria? Vaxzevria must also not be given to people who have previously had capillary leak syndrome
كوفاكس: مصر تتلقى أكثر من 850 ألف جرعة من لقاح أسترازينيكا: Vaxzevria does not contain the virus itself and cannot cause COVID-19
كوفاكس: مصر تتلقى أكثر من 850 ألف جرعة من لقاح أسترازينيكا: Walsh, Nick; Shelley, Jo; Duwe, Eduardo; Bonnett, William 27 July 2020